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In this issue of Immunity, Shi et al. (2008) identify a previously unknown requirement in T helper cell differen-
tiation, showing that Jak3 and STAT5 are needed to generate chromatin that is permissive to the activating
effects of T-bet.A ‘‘pregenomic’’ notion was that some
transcription factors were ‘‘master’’ regu-
lators of certain cellular phenotypes, ap-
plying (perhaps incorrectly) archaic social
structures to the domain of gene regula-
tion. A flood of ‘‘postgenomic’’ data sug-
gests a different view of gene regulatory
networks, emphasizing subtlety and co-
operation in tipping the balance of com-
plex biological systems. In this issue of
Immunity, Shi et al. (2008) provide such
an example, in which a ‘‘master’’ is shown
to operate within the context of previously
unrecognized signals, refining our under-
standing of T helper cell differentiation.
The talented CD4+ T cell plays many
roles in immunity, predominantly helping
to organize the activities of other immune
players on the stage. In doing so, CD4+
T cells adopt a variety of ‘‘personalities’’
(i.e., effector functions), each adapted to
defend against different kinds of patho-
gens; currently, there are three forms of
CD4+ effector subsets, termed T helper
(Th) 1, Th2, and Th-17. It is by the produc-
tion of distinct patterns of cytokines that
these subsets exert their important coor-
dinating activities, and for Th1 cells, this
means producing interferon-g (IFN-g),
which acts in mobilizing cellular immunity
against intracellular pathogens.
For Th1 cells, the transcription factor
T-bet is critical for driving differentiation
and Ifng expression (Szabo et al., 2000).
However, NK cells (and other T cell sub-
sets such as NKT or gdT cells) also use
T-bet for Ifng gene expression (Townsend
et al., 2004) but begin their life with this lo-
cus already poised for expression. So
what is the point of providing CD4+ T cells
with multiple personalities requiring addi-tional layers of gene regulation? Presum-
ably, the immune system benefits from
the CD4+ T cell’s heightened sensitivity
for pathogen detection and capacity for
clonal expansion, promoting sterilizing
immunity and immunological memory.
Therefore, an essential ability of CD4+
T cells is to turn on, and off, various cyto-
kine genes. For this, key cytokine genes
are silenced during thymocyte develop-
ment; when naive CD4+ T cells emerge,
their Ifng shows signs of inactive active
chromatin, such as hypermethylation at
CpG residues, and lacks signs of active
chromatin, such as histone acetylation
(Avni et al., 2002; Fields et al., 2002).
These features are reversed during Th1
cell differentiation through several steps,
involving the cytokines IFN-g and IL-12,
and activation of signal transducer and
activator of transcription (STAT)1 and
STAT4 and several other transcription
factors, most critically T-bet. The proxi-
mal Ifng promoter has several sites that
can bind T-bet (Cho et al., 2003), but be-
yond this, there are several cis-regulatory
elements located at much more distant
sites that contribute to lineage-specific
expression of Ifng. Several of these con-
served noncoding sequences (CNSs) act
as enhancers for Ifng expression in vitro
(Agarwal and Rao, 1998; Lee et al.,
2004; Shnyreva et al., 2004) and can ex-
hibit lineage-specific histone-hyperacety-
lation (Avni et al., 2002; Fields et al., 2002).
Among these, CNS1 (aka CNS-5), located
5 kb upstream, and CNS2 (CNS+17) 17 kb
downstream of the Ifng gene promoter
enhance Ifng expression in a T-bet-de-
pendent manner in Th1 cells (Lee et al.,
2004; Shnyreva et al., 2004). AnotherImmuregion, CNS-22, is essential for Ifng ex-
pression in Th1 cells, cytotoxic T lympho-
cytes (CTLs) and NK cells, binds T-bet in
resting and activated cells, and exhibits
histone hyperacetylation in Th1 and Th2
cells (Hatton et al., 2006). CNS-22 also
has clustered sites for GATA, STAT, IRF,
NF-kB, and Ikaros family transcription
factors and is the only control element
surrounding Ifng to show substantial his-
tone acetylation in naive CD4+ cells or
Th2 cells. Thus, CNS-22 could represent
a ‘‘pioneering’’ chromatin entry point for
the spread of T-bet binding throughout
the Ifng locus during Th1 cell differentia-
tion and may act as an ‘‘interaction plat-
form’’ for T-bet and GATA3 to activate
Ifng in Th1 cells but silence it in Th2 cells
(Hatton et al., 2006).
It is in this context that the study by Shi
et al. (2008) arises. Previous interests of
the Berg laboratory in Jak kinases led to
an examination of potential roles for
Jak3 in Th1 cell differentiation. Quite sur-
prisingly, Jak3/ T cells (or the pharma-
cologic inhibition of Jak3) exhibited a dra-
matic reduction in Ifng gene expression
under Th1-skewing conditions. This re-
duction was not simply due to a defect
in TCR signaling, or to a requirement for
Jak3 in activating STAT1 or STAT4, or to
a requirement for Jak3 in the induction
of T-bet. Indeed, T-bet expression was in-
duced normally in Jak3/ Th1 cells. In-
stead, using chromatin immunoprecipita-
tion (ChIP) assays, Shi et al. (2008) found
a defect in the ability of T-bet to become
associated with the proximal Ifng pro-
moter in Jak3/ Th1 cells. In addition,
Jak3/ T cells revealed a generalized
reduction in histone H3 acetylation of thenity 28, June 2008 ª2008 Elsevier Inc. 725
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PreviewsFigure 1. Action of Jak3 and STAT5 in Th1 Cell Development
As shown in the left panel, the conserved noncoding sequence (CNS)-22, located 22 kb upstream of the interferon-g (Ifng) gene promoter binds T-bet, shows
an active chromatin configuration even in naive CD4+ T cells, and may represent the initial platform of activation. Shi et al. (2008) show that in the absence of
Jak3, T-bet is unable to gain access to sites more proximal to the Ifng promoter. The right panel shows that upon IL-2 signaling, STAT5 itself binds to CNS1
(at 5 kb) and to sites near the promoter, suggesting a model in which IL-2, Jak3, and STAT5 form a system to permit encroachment of T-bet into the Ifng locus.Ifng promoter region. This loss of T-bet
association with the proximal Ifng pro-
moter did not seem to be due to an
inherent defect in the functional activity
of T-bet because transcription of another
target of T-bet, the gene encoding IL-
12Rb2 subunit, was maintained.
The requirement for Jak3 in Th1 cell
differentiation begged the question of
a corresponding cytokine and STAT re-
quirement. Because Jak3 is not used by
receptors for IFN-g or IL-12, Shi et al.
(2008) considered other cytokines that
used the common receptor subunit gc
(which utilizes Jak3) and other STATs
that gc may activate, beginning with IL-2
and STAT5. Again, using ChIP assays,
they found that STAT5 could be detected
to bind to sites in the proximal Ifng pro-
moter and sites in the CNS1 region (at 5
kb) and to bind very weakly to the CNS2
region (+17 kb). Interestingly, the authors
did not find any evidence of STAT5
binding to more distant CNS-22 or CNS-
34 elements, even though these regions
are known to have STAT-binding consen-
sus sequences and to be necessary (in the
case of CNS-22) for induction by IL-12
and IL-18 of IFN-g production (Hatton
et al., 2006). Thus, the distribution of
STAT5 binding to the Ifng locus appears
to be restricted to regions of the genes
that would become activated subse-
quently to the initial interactions of T-bet
with the CNS-22 regions. Finally, the au-
thors also showed a reduction in the per-
centage of IFN-g production by T cells
that were lacking STAT5a and STAT5b ex-
pression. This reduction was not as dra-
matic as that caused by Jak3 deficiency,726 Immunity 28, June 2008 ª2008 Elsevierbut experimentally, it relied on double
Cre-mediated deletion of two STAT5 al-
leles, which may be less than 100% effi-
cient, and could conceivably underrepre-
sent the degree of STAT5-dependence
of the Ifng locus. Blockade of IL-2 signal-
ing also reduced the amount of IFN-g pro-
duction in developing Th1 cells, indicating
that IL-2 and STAT5 play functional roles
in tuning the amount of IFN-g produced
by developing Th1 cells.
Thus, the authors show a role for Jak3,
IL-2 signaling, and STAT5 activation of
the Ifng locus during Th1 cell differentia-
tion. Although many details remain to be
worked out, the data suggest a sequential
(if speculative) model of cooperativity
among CNS regions, T-bet, and STAT5
during activation of Ifng in Th1 cell differ-
entiation. In this model (Figure 1), the
CNS-22 element, which is constitutively
accessible, is the ‘‘pioneering’’ foothold
for T-bet binding near the Ifng locus. Dur-
ing Th1 cell development, T-bet expres-
sion rises, and GATA3 declines; previ-
ously, we would have presumed that this
rising tide of T-bet would gain unfettered
access to the more proximal CNS1 and
then simply wash up onto the Ifng pro-
moter, activating its transcription. But
Shi et al.’s findings suggest that this phase
of Th1 cell development is more finely reg-
ulated, and IL-2, Jak3, and STAT5 act as
‘‘guards,’’ giving permission to T-bet for
entry into the Ifng locus. This regulation
would be enforced by requiring STAT5
binding at CNS1 (and the Ifng promoter)
in order for T-bet to gain access and
spread toward the promoter. Mechanisti-
cally, perhaps STAT5 binding to theInc.CNS1 region may be necessary for T-bet
to interact with specific brachyury-binding
sites in this region; similar cooperativity
has been suggested for factors interacting
at CNS-22, such as direct factor interac-
tions gated by tethering to specific com-
posite DNA-binding sites (Hatton et al.,
2006). By whatever mechanism, without
this ‘‘permission’’ of entry provided by
STAT5 at CNS1, the ‘‘master’’ T-bet would
be prevented from gaining a foothold
nearer to the Ifng promoter.
Clearly much more work is required to
test these notions, and more factors are
likely to be involved. But in any case, Shi
et al.’s study suggests some intriguing
and immediate avenues. It will be interest-
ing to examine whether the ability of
STAT5 to bind these sites is somehow
dependent on T-bet as well and to find
out whether these restrictions in T-bet ac-
cessibility in Jak3/ CD4+ T cells apply to
other lineages of cells, such as NK cells or
CD8+ T cells. Possibly more compelling is
the question of what immunologic benefit
is provided by using the IL-2-Jak3-STAT5
axis to guard the Ifng locus against full ac-
tivation by T-bet. Perhaps this is just one
more example of the pervasive regulatory
actions of IL-2, which seem ever more im-
possible to understand in the pregenomic
mindset of ‘‘on or off.’’
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How do CD1 molecules load lipid
lysosomal pH targets amino acids i
lipid antigens.
X-ray crystallographic studies have re-
vealed the structures of several com-
plexes of lipid antigens bound to different
CD1 isoforms (Zajonc and Kronenberg,
2007). Although these structures show
how the aliphatic chains of diverse anti-
gens fit into pockets in the grooves of
CD1 proteins, they reveal a fundamental
topologic problem. Unlike MHC class I
and class II molecules, the grooves of
CD1 molecules are not open along their
length. The lipid tails are buried, and a por-
tal over what is usually called the F0 pocket,
toward the carboxyl terminal of the a heli-
ces, permits the emergence of the hydro-
philic head groups of CD1-bound antigens
(Zajonc and Kronenberg, 2007). Antigens
with long hydrophobic chains therefore
somehow must traverse a relatively small
portal in the roof of the CD1 molecules to
enter the antigen-binding groove. Now,
a comprehensive report in this issue (Re-
lloso et al., 2008) has combined modeling
with immunochemical methods to provide
a better understanding of the mechanism
of insertion of lipids into the CD1 groove.
CD1 proteins are a family of antigen-pre-
senting molecules found in most verte-
brates. Their hydrophobic grooves present
lipid antigens, which are mostly glyco-
lipids. The CD1 gene family contains evo-
lutionarily divergent members that are
not uniformly represented in differentLee, D.U., Avni, O., Chen, L., and Rao, A. (2004). J.
Biol. Chem. 279, 4802–4810.
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n CD1b, causing it to open and attain
species (Dascher, 2007). For example, in
humans there are four CD1 isotypes—
CD1a, CD1b, CD1c, and CD1d—but only
a CD1d ortholog in mice. CD1-reactive
T cells have a unique biology. Natural killer
T (NK T) cells with an invariant TCRa chain
recognize CD1d. These NKT cells share
features with innate immune cells, and, at
least in mice, they are critical for the regu-
lation of many immune responses (Bende-
lac et al., 2007). The human CD1a, CD1b,
and CD1c proteins, by contrast, present
lipids from mycobacterial species to T lym-
phocytes with diverse antigen receptors.
The properties of these mycobacterial-re-
active T cells suggest that they constitute
part of the adaptive immune response for
host defense (Barral and Brenner, 2007).
Working with lipids presents special
challenges, as they are famously sticky,
and, moreover, unlike peptides they mostly
exist in organized macromolecular struc-
tures, such as micelles and bilayers. De-
spite this, it has beenpossible tomakesub-
stantial progress in understanding how
CD1 proteins get loaded with lipid-contain-
ing antigens, in part by following the route
of CD1 molecules in antigen-presenting
cells (APCs). As outlined in Figure 1, CD1
polypeptides assemble with autologous
phospholipids, such as phosphatidylcho-
line, and spacer lipids in the endoplasmic
reticulum (Barral and Brenner, 2007; De
ImmuSzabo, S.J., Kim, S.T., Costa, G.L., Zhang, X.K.,
Fathman, C.G., and Glimcher, L.H. (2000). Cell
100, 655–669.
Townsend, M.J., Weinmann, A.S., Matsuda, J.L.,
Salomon, R., Farnham, P.J., Biron, C.A., Gapin,
L., and Glimcher, L.H. (2004). Immunity 20, 477–
494.Groove
Relloso et al. (2008) uncover how
a conformation more receptive to
Libero and Mori, 2008; Garcia-Alles et al.,
2006). After transport to the cell surface,
either directly from the Golgi network or
through an endosomal intermediate, CD1
isoforms subsequently are internalized,
and they recycle through endosomal com-
partments, where self-phospholipids are
exchanged for various self- and foreign
antigens. Interestingly, different CD1 mole-
cules are adapted to survey different endo-
somal compartments. For example, CD1a
recycles through early endosomes, but hu-
man CD1b and mouse CD1d make their
way deep into lysosomal compartments
to acquire antigens (Barral and Brenner,
2007; De Libero and Mori, 2008).
Sphingolipid activator proteins, includ-
ing the four saposins and the GM2 activa-
tor protein, as well as the Niemann-Pick
type C2 protein, are important for lipid
antigen exchange in lysosomes, thereby
augmenting CD1-mediated antigen pre-
sentation (Barral and Brenner, 2007; De
Libero and Mori, 2008). Some of these
proteins perturb membranes, thereby
making glycolipids more susceptible to
interaction with other proteins, whereas
others may directly facilitate lipid ex-
change with membranes. Not only do
they colocalize in late endosomes and ly-
sosomes with CD1 molecules, but several
sphingolipid activator proteins also bind
to CD1. Despite these recent advances,
nity 28, June 2008 ª2008 Elsevier Inc. 727
